10 Pharmaceutical Stocks to Buy Today According to Tiger Cub Billionaire Lee Ainslie
In this article, we will take a look at 10 pharmaceutical stocks to buy today according to Tiger Cub Billionaire Lee Ainslie.
Wave Life Sciences Ltd. (WVE)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Maverick Capital Lee Ainslie | 5,593,389 | $11,187 | 0.2% | |
| 2. | Platinum Asset Management Kerr Neilson | 1,336,105 | $2,672 | 0.08% | |
| 3. | Ikarian Capital Neil Shahrestani | 1,048,039 | $2,095 | +6% | 0.27% |
| 4. | Nantahala Capital Management Wilmot B. Harkey And Daniel Mack | 819,101 | $1,638 | -10% | 0.07% |
| 5. | 683 Capital Partners Ari Zweiman | 462,047 | $924 | +147% | 0.04% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $38.00 | 263,158 | Large Shareholder, Director | 7,775,207 | 2019-01-24 | Filing | |
| $24.00 | 23,398 | Large Shareholder, Director | 7,512,049 | 2017-11-14 | Filing | |
| $23.30 | 400,000 | Large Shareholder, Director | 7,488,651 | 2017-11-13 | Filing | |
| $16.00 | 125,000 | Large Shareholder, Director | 1,984,130 | 2015-11-16 | Filing | |
| $16.00 | 76,250 | Large Shareholder, Director | 3,228,690 | 2015-11-16 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $1.72 | 16,714 | Officer | 111,095 | 2022-05-05 | Filing | |
| $1.72 | 33,501 | Officer, Director | 436,825 | 2022-05-05 | Filing | |
| $1.72 | 5,021 | Officer | 84,567 | 2022-05-05 | Filing | |
| $1.72 | 16,714 | Officer | 109,103 | 2022-05-05 | Filing | |
| $1.72 | 10,867 | Officer | 89,972 | 2022-05-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 5,850,000 | $11,700 | 10.75% | |
| 2. | 4,562,858 | $9,126 | 0.1% | |
| 3. | 4,561,275 | $9,123 | 0% | |
| 4. | 2,937,786 | $5,876 | 0% | |
| 5. | 1,911,728 | $3,823 | 1.24% |
News See All
Hedge Funds Are Selling WAVE Life Sciences Ltd. (WVE)
The latest 13F reporting period has come and gone, and Insider Monkey is again at the forefront when it comes to making use of this gold mine of data.
Is WVE Stock A Buy or Sell?
Last year we predicted the arrival of the first US recession since 2009 and we told in advance that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
10 Best Small-Cap Biotech Stocks Under $10 in 2021
We like healthcare and technology industries because of their above-average long-term growth prospects. Biotechnology is at the intersection of healthcare and technology.
5 Best Small-Cap Biotech Stocks Under $10 in 2021
Below we presented the list of 5 best small-cap biotech stocks under $10 in 2021.
Did Hedge Funds Drop The Ball On WAVE Life Sciences Ltd. (WVE) ?
It seems that the masses and most of the financial media hate hedge funds and what they do, but why is this hatred of hedge funds so prominent? At the end of the day, these asset management firms do not...
Is WAVE Life Sciences Ltd. (WVE) Going To Burn These Hedge Funds ?
Looking for stocks with high upside potential? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge ...
Is WAVE Life Sciences Ltd. (WVE) A Good Stock To Buy ?
Is WAVE Life Sciences Ltd. (NASDAQ:WVE) a good equity to bet on right now? We like to check what the smart money thinks first before doing extensive research.
13D Filing: RA Capital Management and Wave Life Sciences Ltd (WVE)
Wave Life Sciences Ltd (NASDAQ:WVE): Peter Kolchinsky's RA Capital Management filed an amended 13D.
You can check out RA Capital Management's latest holdings and filings here.
Billionaire Hedge Funds
